DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Corren J, Weinstein S, Janka L. et al.
Phase 3 Study of Reslizumab in Patients With Poorly Controlled Asthma: Effects Across a Broad Range of Eosinophil Counts.
Chest 2016;
150: 799-810
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.